Patents by Inventor Michael Sano

Michael Sano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230384914
    Abstract: Examples provide an accessibility manager enabling a persistent floating secondary stage for presentation of user-configurable content during a video conferencing meeting. A primary stage is provided during each video conferencing meeting. The primary stage includes a roster of meeting attendees and an area for displaying shared content. The user creates configurable settings which are used at every meeting to generate a customized secondary stage. The secondary stage is an overlay which persists on the user interface even if the primary stage is minimized as the user multi-tasks during the meeting. The secondary stage displays video feed for one or more selected meeting attendees, such as an interpreter. When an interpreter speaks on behalf of the user, the user receives the active speaker attribution. The configurable settings permit the user to control the secondary stage video feed quality, sizing, aspect ratio, display location, captioning, role designation and active speaker designation.
    Type: Application
    Filed: February 14, 2023
    Publication date: November 30, 2023
    Inventors: Toby Jonathan FITCH, Christopher Michael SANO
  • Patent number: 11614854
    Abstract: Examples provide an accessibility manager enabling a persistent floating secondary stage for presentation of user-configurable content during a video conferencing meeting. A primary stage is provided during each video conferencing meeting. The primary stage includes a roster of meeting attendees and an area for displaying shared content. The user creates configurable settings which are used at every meeting to generate a customized secondary stage. The secondary stage is an overlay which persists on the user interface even if the primary stage is minimized as the user multi-tasks during the meeting. The secondary stage displays video feed for one or more selected meeting attendees, such as an interpreter. When an interpreter speaks on behalf of the user, the user receives the active speaker attribution. The configurable settings permit the user to control the secondary stage video feed quality, sizing, aspect ratio, display location, captioning, role designation and active speaker designation.
    Type: Grant
    Filed: May 28, 2022
    Date of Patent: March 28, 2023
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Toby Jonathan Fitch, Christopher Michael Sano
  • Patent number: 10994133
    Abstract: A ratio of reversible electroporation and irreversible electroporation may be controlled by selecting a symmetric waveform or asymmetric waveform to either minimize or enhance irreversible effects on cells in the target tissue. Combined reversible and irreversible electroporation includes inserting one or more therapeutic electrodes into a target tissue, introducing an electroporation compound into the target tissue, selecting a pulse waveform that is either 1) asymmetric bipolar that has positive and negative pulses with different durations, or 2) symmetric bipolar that has positive and negative pulses with the same duration, and delivering to the target tissue a series of electrical pulses having the selected pulse waveform.
    Type: Grant
    Filed: February 4, 2020
    Date of Patent: May 4, 2021
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Michael Sano, Lei Xing
  • Publication number: 20200171303
    Abstract: A ratio of reversible electroporation and irreversible electroporation may be controlled by selecting a symmetric waveform or asymmetric waveform to either minimize or enhance irreversible effects on cells in the target tissue. Combined reversible and irreversible electroporation includes inserting one or more therapeutic electrodes into a target tissue, introducing an electroporation compound into the target tissue, selecting a pulse waveform that is either 1) asymmetric bipolar that has positive and negative pulses with different durations, or 2) symmetric bipolar that has positive and negative pulses with the same duration, and delivering to the target tissue a series of electrical pulses having the selected pulse waveform.
    Type: Application
    Filed: February 4, 2020
    Publication date: June 4, 2020
    Inventors: Michael Sano, Lei Xing
  • Patent number: 10589092
    Abstract: A ratio of reversible electroporation and irreversible electroporation may be controlled by selecting a symmetric waveform or asymmetric waveform to either minimize or enhance irreversible effects on cells in the target tissue. Combined reversible and irreversible electroporation includes inserting one or more therapeutic electrodes into a target tissue, introducing an electroporation compound into the target tissue, selecting a pulse waveform that is either 1) asymmetric bipolar that has positive and negative pulses with different durations, or 2) symmetric bipolar that has positive and negative pulses with the same duration, and delivering to the target tissue a series of electrical pulses having the selected pulse waveform.
    Type: Grant
    Filed: June 7, 2017
    Date of Patent: March 17, 2020
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Michael Sano, Lei Xing
  • Publication number: 20170348525
    Abstract: A ratio of reversible electroporation and irreversible electroporation may be controlled by selecting a symmetric waveform or asymmetric waveform to either minimize or enhance irreversible effects on cells in the target tissue. Combined reversible and irreversible electroporation includes inserting one or more therapeutic electrodes into a target tissue, introducing an electroporation compound into the target tissue, selecting a pulse waveform that is either 1) asymmetric bipolar that has positive and negative pulses with different durations, or 2) symmetric bipolar that has positive and negative pulses with the same duration, and delivering to the target tissue a series of electrical pulses having the selected pulse waveform.
    Type: Application
    Filed: June 7, 2017
    Publication date: December 7, 2017
    Inventors: Michael Sano, Lei Xing